Sphingosine kinase 2 and multiple myeloma

Pyne, Nigel J. and Pyne, Susan (2017) Sphingosine kinase 2 and multiple myeloma. Oncotarget, 8 (24). pp. 43596-43597. 17420. ISSN 1949-2553 (https://doi.org/10.18632/oncotarget.17420)

Preview

Text. Filename: Pyne_Pyne_Oncotarget_2017_Sphingosine_kinase_2_and_multiple_myeloma.pdf Final Published Version License: Download (675kB)| Preview

Abstract

News on: Sphingosine kinase 2 inhibition synergises with bortezomib to target myeloma by enhancing endoplasmic reticulum stress, by Wallington-Beddoe et al. Oncotarget. 2017; doi: 10.18632/oncotarget.17115.

ORCID iDs

Pyne, Nigel J. ORCID: https://orcid.org/0000-0002-5657-4578

Pyne, Susan ORCID: https://orcid.org/0000-0002-6608-9584

• Share and Export
  

  RefWorksRIS (EndNote Online, Zotero, Ref manager, etc)RDF+XMLEndNoteASCII CitationOpenURL ContextObject in SpanMPEG-21 DIDLRIOXX2 XMLBibTeXAtomEP3 XMLDublin CoreRDF+N-TriplesMODSHTML CitationJSONData Cite XMLRDF+N3Multiline CSVOpenURL ContextObjectReferSimple MetadataMETS
• Item metadata

  Item type:	Article
  ID code:	61524
  Dates:	Date Event 25 April 2017 Published 17 April 2017 Accepted
  Subjects:	Medicine > Internal medicine > Neoplasms. Tumors. Oncology (including Cancer) Medicine > Therapeutics. Pharmacology
  Department:	Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
  Depositing user:	Pure Administrator
  Date deposited:	08 Aug 2017 16:26
  Last modified:	11 Nov 2024 11:42
  URI:	https://strathprints.strath.ac.uk/id/eprint/61524